Page last updated: 2024-10-25

cinoxacin and Urinary Bladder Neoplasms

cinoxacin has been researched along with Urinary Bladder Neoplasms in 1 studies

Cinoxacin: Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
cinoxacin : A member of the class of cinnolines that is 6,7-methylenedioxycinnolin-4(1H)-one bearing an ethyl group at position 1 and a carboxylic acid group at position 3. An analogue of oxolinic acid, it has similar antibacterial actions. It was formerly used for the treatment of urinary tract infections.

Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.

Research Excerpts

ExcerptRelevanceReference
"Cinoxacin is an oral synthetic antibacterial agent, of the second generation quinolones group, with excellent efficacy in respiratory, intra-abdominal, pelvic, and skin and soft tissue infections."5.32Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction. ( Emiliani, F; Quercia, O; Rafanelli, S; Stefanini, GF, 2003)
"Cinoxacin is an oral synthetic antibacterial agent, of the second generation quinolones group, with excellent efficacy in respiratory, intra-abdominal, pelvic, and skin and soft tissue infections."1.32Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction. ( Emiliani, F; Quercia, O; Rafanelli, S; Stefanini, GF, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quercia, O1
Rafanelli, S1
Emiliani, F1
Stefanini, GF1

Other Studies

1 other study available for cinoxacin and Urinary Bladder Neoplasms

ArticleYear
Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction.
    European annals of allergy and clinical immunology, 2003, Volume: 35, Issue:2

    Topics: 4-Quinolones; Anaphylaxis; Anti-Infective Agents; Cinoxacin; Double-Blind Method; Humans; Inflammati

2003